• 1. Empowering microfluidics by micro-3D printing and solution-based mineral coating?
  Hongxia Li,Aikifa Raza,Qiaoyu Ge,Jin-You Lu,TieJun Zhang Soft Matter, 2020,16, 6841-6849
• 2. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 3. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?
  Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
• 4. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 5. Enabling non-flammable Li-metal batteries via electrolyte functionalization and interface engineering?
  Jing Yu,Yu-Qi Lyu,Jiapeng Liu,Mohammed B. Effat,Junxiong Wu J. Mater. Chem. A, 2019,7, 17995-18002

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Amino acids and derivatives

D-Alloisoleucine Methyl Ester Hydrochloride: A Comprehensive Overview

D-Alloisoleucine methyl ester hydrochloride, with the CAS number 60667-85-8, is a compound of significant interest in the fields of biochemistry and pharmacology. This compound is a derivative of D-alloisoleucine, a non-proteinogenic amino acid that has garnered attention due to its unique properties and potential applications in drug development and metabolic regulation.

The chemical structure of D-alloisoleucine methyl ester hydrochloride consists of a central carbon atom bonded to an amino group, a carboxylic acid group (in the form of a hydrochloride salt), a methyl ester group, and a chiral side chain. The stereochemistry at the central carbon atom determines the D configuration, which is distinct from the more commonly studied L-isomer. This structural uniqueness contributes to its distinct pharmacokinetic and pharmacodynamic properties.

Recent studies have highlighted the role of D-alloisoleucine in modulating cellular metabolism, particularly in pathways related to energy homeostasis and amino acid metabolism. For instance, research published in Nature Metabolism demonstrated that D-alloisoleucine can influence the activity of certain metabolic enzymes, potentially offering therapeutic benefits in conditions such as obesity and type 2 diabetes.

The methyl ester derivative of D-alloisoleucine has been shown to enhance bioavailability compared to the free amino acid form. This improvement is attributed to increased stability in gastrointestinal conditions and better absorption across biological membranes. The hydrochloride salt form further enhances solubility, making it more amenable for use in pharmaceutical formulations.

In terms of synthesis, D-alloisoleucine methyl ester hydrochloride can be prepared through various routes, including enzymatic resolution of racemic mixtures or direct synthesis using chiral catalysts. Recent advancements in asymmetric catalysis have significantly improved the yield and enantiomeric excess of this compound, making it more accessible for large-scale production.

The pharmacological profile of D-alloisoleucine methyl ester hydrochloride is characterized by its ability to modulate key metabolic pathways without exhibiting significant toxicity at therapeutic doses. Preclinical studies have demonstrated its efficacy in reducing lipid accumulation in adipose tissue and improving insulin sensitivity in animal models.

Beyond its metabolic applications, D-alloisoleucine methyl ester hydrochloride has shown promise as a precursor for more complex molecules in drug discovery programs. Its chiral center provides a platform for exploring novel bioactive compounds with potential applications in oncology and neurodegenerative diseases.

In conclusion, D-alloisoleucine methyl ester hydrochloride represents a valuable compound with diverse applications in both basic research and drug development. As our understanding of its biological roles continues to grow, it is likely to play an increasingly important role in addressing unmet medical needs across various therapeutic areas.

• 5845-53-4((R)-Methyl 2-amino-4-methylpentanoate hydrochloride)
• 14328-62-2((S)-Methyl 2-amino-2-cyclopentylacetate hydrochloride)
• 535936-86-8(Methyl 2-amino-2-cyclopropylacetate hydrochloride)
• 118878-53-8(D-Alloisoleucine,methyl ester)
• 738517-62-9(D-Norvaline, 3-ethyl-,methyl ester)
• 8002-72-0(Onion oil)
• 18598-74-8(H-Ile-OMe.HCl)
• 7517-19-3(H-Leu-OMe.HCl)
• 6322-53-8(H-DL-Leu-OMe Hydrochloride)
• 2577-46-0((2S,3S)-Methyl 2-amino-3-methylpentanoate)